| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,667 |
8,617 |
$233K |
| 99050 |
|
6,884 |
5,770 |
$228K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,358 |
5,944 |
$213K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,400 |
1,126 |
$75K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,930 |
2,798 |
$24K |
| 99243 |
|
1,469 |
1,347 |
$20K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
337 |
337 |
$19K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
907 |
768 |
$16K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,452 |
2,352 |
$10K |
| 87501 |
|
690 |
681 |
$3K |
| 81000 |
|
1,387 |
1,329 |
$2K |
| 87634 |
|
277 |
277 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
113 |
101 |
$2K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
54 |
54 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
106 |
96 |
$646.79 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
173 |
167 |
$472.25 |
| 87486 |
|
52 |
52 |
$155.33 |
| 87581 |
|
52 |
52 |
$155.33 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
84 |
83 |
$91.11 |
| 81002 |
|
55 |
52 |
$12.89 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$6.99 |